Literature DB >> 21160474

Genetic variegation of clonal architecture and propagating cells in leukaemia.

Kristina Anderson1, Christoph Lutz, Frederik W van Delft, Caroline M Bateman, Yanping Guo, Susan M Colman, Helena Kempski, Anthony V Moorman, Ian Titley, John Swansbury, Lyndal Kearney, Tariq Enver, Mel Greaves.   

Abstract

Little is known of the genetic architecture of cancer at the subclonal and single-cell level or in the cells responsible for cancer clone maintenance and propagation. Here we have examined this issue in childhood acute lymphoblastic leukaemia in which the ETV6-RUNX1 gene fusion is an early or initiating genetic lesion followed by a modest number of recurrent or 'driver' copy number alterations. By multiplexing fluorescence in situ hybridization probes for these mutations, up to eight genetic abnormalities can be detected in single cells, a genetic signature of subclones identified and a composite picture of subclonal architecture and putative ancestral trees assembled. Subclones in acute lymphoblastic leukaemia have variegated genetics and complex, nonlinear or branching evolutionary histories. Copy number alterations are independently and reiteratively acquired in subclones of individual patients, and in no preferential order. Clonal architecture is dynamic and is subject to change in the lead-up to a diagnosis and in relapse. Leukaemia propagating cells, assayed by serial transplantation in NOD/SCID IL2Rγ(null) mice, are also genetically variegated, mirroring subclonal patterns, and vary in competitive regenerative capacity in vivo. These data have implications for cancer genomics and for the targeted therapy of cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21160474     DOI: 10.1038/nature09650

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  50 in total

1.  Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion.

Authors:  I F Loncarevic; B Roitzheim; J Ritterbach; S Viehmann; A Borkhardt; F Lampert; J Harbott
Journal:  Genes Chromosomes Cancer       Date:  1999-03       Impact factor: 5.006

Review 2.  Cancer stem cells: back to Darwin?

Authors:  Mel Greaves
Journal:  Semin Cancer Biol       Date:  2010-03-30       Impact factor: 15.707

3.  Genetic clonal diversity predicts progression to esophageal adenocarcinoma.

Authors:  Carlo C Maley; Patricia C Galipeau; Jennifer C Finley; V Jon Wongsurawat; Xiaohong Li; Carissa A Sanchez; Thomas G Paulson; Patricia L Blount; Rosa-Ana Risques; Peter S Rabinovitch; Brian J Reid
Journal:  Nat Genet       Date:  2006-03-26       Impact factor: 38.330

4.  TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia.

Authors:  Jan Zuna; Anthony M Ford; Martina Peham; Naina Patel; Vaskar Saha; Cornelia Eckert; Joachim Köchling; Renate Panzer-Grümayer; Jan Trka; Mel Greaves
Journal:  Clin Cancer Res       Date:  2004-08-15       Impact factor: 12.531

Review 5.  Breast cancer: origins and evolution.

Authors:  Kornelia Polyak
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

6.  Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; Letha A Phillips; Xiaoping Su; Jing Ma; Christopher B Miller; Sheila A Shurtleff; James R Downing
Journal:  Science       Date:  2008-11-28       Impact factor: 47.728

7.  Cancer genome sequencing--an interim analysis.

Authors:  Edward J Fox; Jesse J Salk; Lawrence A Loeb
Journal:  Cancer Res       Date:  2009-06-09       Impact factor: 12.701

8.  Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer.

Authors:  M R Teixeira; N Pandis; G Bardi; J A Andersen; S Heim
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

9.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962

10.  Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.

Authors:  Niklas Feldhahn; Nadine Henke; Kai Melchior; Cihangir Duy; Bonaventure Ndikung Soh; Florian Klein; Gregor von Levetzow; Bernd Giebel; Aihong Li; Wolf-Karsten Hofmann; Hassan Jumaa; Markus Müschen
Journal:  J Exp Med       Date:  2007-05-07       Impact factor: 14.307

View more
  364 in total

Review 1.  Control dominating subclones for managing cancer progression and posttreatment recurrence by subclonal switchboard signal: implication for new therapies.

Authors:  Shengwen Calvin Li; Katherine L Lee; Jane Luo
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

Review 2.  Drug resistance: still a daunting challenge to the successful treatment of AML.

Authors:  Brian C Shaffer; Jean-Pierre Gillet; Chirayu Patel; Maria R Baer; Susan E Bates; Michael M Gottesman
Journal:  Drug Resist Updat       Date:  2012-03-11       Impact factor: 18.500

Review 3.  Genomic profiling of B-progenitor acute lymphoblastic leukemia.

Authors:  Charles G Mullighan
Journal:  Best Pract Res Clin Haematol       Date:  2011-11-06       Impact factor: 3.020

4.  Intra-hematopoietic cell fusion as a source of somatic variation in the hematopoietic system.

Authors:  Amy M Skinner; Markus Grompe; Peter Kurre
Journal:  J Cell Sci       Date:  2012-03-05       Impact factor: 5.285

5.  Clonal architecture of secondary acute myeloid leukemia.

Authors:  Matthew J Walter; Dong Shen; Li Ding; Jin Shao; Daniel C Koboldt; Ken Chen; David E Larson; Michael D McLellan; David Dooling; Rachel Abbott; Robert Fulton; Vincent Magrini; Heather Schmidt; Joelle Kalicki-Veizer; Michelle O'Laughlin; Xian Fan; Marcus Grillot; Sarah Witowski; Sharon Heath; John L Frater; William Eades; Michael Tomasson; Peter Westervelt; John F DiPersio; Daniel C Link; Elaine R Mardis; Timothy J Ley; Richard K Wilson; Timothy A Graubert
Journal:  N Engl J Med       Date:  2012-03-14       Impact factor: 91.245

6.  Genetics: Personalized medicine and tumour heterogeneity.

Authors:  Rebecca Kirk
Journal:  Nat Rev Clin Oncol       Date:  2012-03-20       Impact factor: 66.675

7.  Counting stem cells: methodological constraints.

Authors:  Leonid V Bystrykh; Evgenia Verovskaya; Erik Zwart; Mathilde Broekhuis; Gerald de Haan
Journal:  Nat Methods       Date:  2012-05-30       Impact factor: 28.547

Review 8.  Vaccines targeting cancer stem cells: are they within reach?

Authors:  Madhav V Dhodapkar; Kavita M Dhodapkar
Journal:  Cancer J       Date:  2011 Sep-Oct       Impact factor: 3.360

Review 9.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 10.  Tracking cells in their native habitat: lineage tracing in epithelial neoplasia.

Authors:  Maria P Alcolea; Philip H Jones
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.